The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx

Inflammatory diseases of the pharynx constitute one of the most significant nosologies groups in the ENT organ diseases profile. According to modern epidemiological data, acute and chronic tonsillopharyngitis are inferior only to influenza and other forms of ARVI with predominantly nasal and paranas...

Full description

Bibliographic Details
Main Authors: S. V. Ryazantsev, D. D. Kalyapin
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-11-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/2772
_version_ 1827962366829002752
author S. V. Ryazantsev
D. D. Kalyapin
author_facet S. V. Ryazantsev
D. D. Kalyapin
author_sort S. V. Ryazantsev
collection DOAJ
description Inflammatory diseases of the pharynx constitute one of the most significant nosologies groups in the ENT organ diseases profile. According to modern epidemiological data, acute and chronic tonsillopharyngitis are inferior only to influenza and other forms of ARVI with predominantly nasal and paranasal sinuses, as well as the lower respiratory tract inflammation in prevalence among the population. Infectious pathogens are the most common etiology of inflammatory diseases of the pharynx. Accordingly, the pharmacological agents should be selected among the drugs having pronounced antimicrobial activity against both bacterial and other organisms - viral and fungal, and an analgesic effect, as sore throat is the main symptom of tonsillofingitis. The combination preparation Septolete® total is one of such drugs.
first_indexed 2024-04-09T16:40:55Z
format Article
id doaj.art-9c3bd021f2204d8d9f16a21e899512b3
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:40:55Z
publishDate 2018-11-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-9c3bd021f2204d8d9f16a21e899512b32023-04-23T06:56:41ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-11-01020555710.21518/2079-701X-2018-20-55-572714The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynxS. V. Ryazantsev0D. D. Kalyapin1Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. PetersburgSaint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. PetersburgInflammatory diseases of the pharynx constitute one of the most significant nosologies groups in the ENT organ diseases profile. According to modern epidemiological data, acute and chronic tonsillopharyngitis are inferior only to influenza and other forms of ARVI with predominantly nasal and paranasal sinuses, as well as the lower respiratory tract inflammation in prevalence among the population. Infectious pathogens are the most common etiology of inflammatory diseases of the pharynx. Accordingly, the pharmacological agents should be selected among the drugs having pronounced antimicrobial activity against both bacterial and other organisms - viral and fungal, and an analgesic effect, as sore throat is the main symptom of tonsillofingitis. The combination preparation Septolete® total is one of such drugs.https://www.med-sovet.pro/jour/article/view/2772inflammatory diseases of the pharynxlocal antisepticsseptolete® total
spellingShingle S. V. Ryazantsev
D. D. Kalyapin
The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
Медицинский совет
inflammatory diseases of the pharynx
local antiseptics
septolete® total
title The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
title_full The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
title_fullStr The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
title_full_unstemmed The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
title_short The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
title_sort next generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
topic inflammatory diseases of the pharynx
local antiseptics
septolete® total
url https://www.med-sovet.pro/jour/article/view/2772
work_keys_str_mv AT svryazantsev thenextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx
AT ddkalyapin thenextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx
AT svryazantsev nextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx
AT ddkalyapin nextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx